Weight management expert Dr Konstantina Fyta has conducted a trial to assess the impact of NES Infoceuticals on the quality of life in clinically overweight individuals.

Objective:

The purpose of this study was to evaluate the efficacy of the NES Health Infoceuticals on health-related quality of life and weight loss in overweight and obese individuals.

Study Details:

Following the completion of the NES Health Infoceutical programme over a two month period, all participants reported higher IWQOL-Lite scores than their baseline scores (changes range from 1.9-18.3) and four of the seven participants demonstrated clinically meaningful change. Several improvements on the nervous, digestive, circulatory, muscular, immune and urinary systems have been also revealed. Bioelectrical Impedance Analysis (BIA) revealed a decreased body fat mass index (BFFM) and body fat percentage and an increase of their lean mass, fat free mass index (FFMI) and body water respectively.

NES Health Infoceuticals were associated with signicantly improved quality of life, increased body lean mass and reduced body fat.